| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/20/2023 | 168.66% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 08/29/2023 | 168.66% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 08/29/2023 | 586.57% | Cantor Fitzgerald | → $23 | Reiterates | Overweight → Overweight |
| 08/18/2023 | 168.66% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/24/2023 | 168.66% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/18/2023 | 168.66% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/15/2023 | 168.66% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 04/24/2023 | 168.66% | HC Wainwright & Co. | → $9 | Initiates Coverage On | → Buy |
| 11/23/2022 | 258.21% | Piper Sandler | $19 → $12 | Maintains | Overweight |
| 04/14/2022 | 497.01% | Cantor Fitzgerald | → $20 | Initiates Coverage On | → Overweight |
| 04/08/2022 | 467.16% | Piper Sandler | → $19 | Initiates Coverage On | → Overweight |
| 04/04/2022 | 526.87% | Citigroup | → $21 | Initiates Coverage On | → Buy |
What is the target price for Alpha Tau Medical (DRTS)?
The latest price target for Alpha Tau Medical (NASDAQ: DRTS) was reported by HC Wainwright & Co. on September 20, 2023. The analyst firm set a price target for $9.00 expecting DRTS to rise to within 12 months (a possible 168.66% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alpha Tau Medical (DRTS)?
The latest analyst rating for Alpha Tau Medical (NASDAQ: DRTS) was provided by HC Wainwright & Co., and Alpha Tau Medical reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Alpha Tau Medical (DRTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on September 20, 2023 so you should expect the next rating to be made available sometime around September 20, 2024.
Is the Analyst Rating Alpha Tau Medical (DRTS) correct?
While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a reiterated with a price target of $0.00 to $9.00. The current price Alpha Tau Medical (DRTS) is trading at is $3.35, which is within the analyst's predicted range.